Cargando…

Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease

Autosomal dominant polycystic kidney disease (ADPKD) has been associated with cardiac abnormalities including mitral valve prolapse and aneurysmal dilatation of the aortic root. Herein, we investigated the potential association of pericardial effusion with ADPKD. Subjects with ADPKD (n = 117) and co...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jin, Fujikura, Kana, Dev, Hreedi, Riyahi, Sadjad, Blumenfeld, Jon, Kim, Jiwon, Rennert, Hanna, Prince, Martin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879333/
https://www.ncbi.nlm.nih.gov/pubmed/35207400
http://dx.doi.org/10.3390/jcm11041127
_version_ 1784658873912655872
author Liu, Jin
Fujikura, Kana
Dev, Hreedi
Riyahi, Sadjad
Blumenfeld, Jon
Kim, Jiwon
Rennert, Hanna
Prince, Martin R.
author_facet Liu, Jin
Fujikura, Kana
Dev, Hreedi
Riyahi, Sadjad
Blumenfeld, Jon
Kim, Jiwon
Rennert, Hanna
Prince, Martin R.
author_sort Liu, Jin
collection PubMed
description Autosomal dominant polycystic kidney disease (ADPKD) has been associated with cardiac abnormalities including mitral valve prolapse and aneurysmal dilatation of the aortic root. Herein, we investigated the potential association of pericardial effusion with ADPKD. Subjects with ADPKD (n = 117) and control subjects without ADPKD matched for age, gender and renal function (n = 117) undergoing MRI including ECG-gated cine MRI of the aorta and heart were evaluated for pericardial effusion independently by three observers measuring the maximum pericardial effusion thickness in diastole using electronic calipers. Pericardial effusion thickness was larger in ADPKD subjects compared to matched controls (Mann–Whitney p = 0.001) with pericardial effusion thickness >5 mm observed in 24 of 117 (21%) ADPKD subjects compared to 4 of 117 (3%) controls (p = 0.00006). Pericardial effusion thickness in ADPKD was associated with female gender patients (1.2 mm greater than in males, p = 0.03) and pleural effusion thickness (p < 0.001) in multivariate analyses. No subjects exhibited symptoms related to pericardial effusion or required pericardiocentesis. In conclusion, pericardial effusion appears to be more prevalent in ADPKD compared to controls. Although in this retrospective cross-sectional study we did not identify clinical significance, future investigations of pericardial effusion in ADPKD subjects may help to more fully understand its role in this disease.
format Online
Article
Text
id pubmed-8879333
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88793332022-02-26 Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease Liu, Jin Fujikura, Kana Dev, Hreedi Riyahi, Sadjad Blumenfeld, Jon Kim, Jiwon Rennert, Hanna Prince, Martin R. J Clin Med Article Autosomal dominant polycystic kidney disease (ADPKD) has been associated with cardiac abnormalities including mitral valve prolapse and aneurysmal dilatation of the aortic root. Herein, we investigated the potential association of pericardial effusion with ADPKD. Subjects with ADPKD (n = 117) and control subjects without ADPKD matched for age, gender and renal function (n = 117) undergoing MRI including ECG-gated cine MRI of the aorta and heart were evaluated for pericardial effusion independently by three observers measuring the maximum pericardial effusion thickness in diastole using electronic calipers. Pericardial effusion thickness was larger in ADPKD subjects compared to matched controls (Mann–Whitney p = 0.001) with pericardial effusion thickness >5 mm observed in 24 of 117 (21%) ADPKD subjects compared to 4 of 117 (3%) controls (p = 0.00006). Pericardial effusion thickness in ADPKD was associated with female gender patients (1.2 mm greater than in males, p = 0.03) and pleural effusion thickness (p < 0.001) in multivariate analyses. No subjects exhibited symptoms related to pericardial effusion or required pericardiocentesis. In conclusion, pericardial effusion appears to be more prevalent in ADPKD compared to controls. Although in this retrospective cross-sectional study we did not identify clinical significance, future investigations of pericardial effusion in ADPKD subjects may help to more fully understand its role in this disease. MDPI 2022-02-21 /pmc/articles/PMC8879333/ /pubmed/35207400 http://dx.doi.org/10.3390/jcm11041127 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Liu, Jin
Fujikura, Kana
Dev, Hreedi
Riyahi, Sadjad
Blumenfeld, Jon
Kim, Jiwon
Rennert, Hanna
Prince, Martin R.
Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease
title Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease
title_full Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease
title_fullStr Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease
title_full_unstemmed Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease
title_short Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease
title_sort pericardial effusion on mri in autosomal dominant polycystic kidney disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879333/
https://www.ncbi.nlm.nih.gov/pubmed/35207400
http://dx.doi.org/10.3390/jcm11041127
work_keys_str_mv AT liujin pericardialeffusiononmriinautosomaldominantpolycystickidneydisease
AT fujikurakana pericardialeffusiononmriinautosomaldominantpolycystickidneydisease
AT devhreedi pericardialeffusiononmriinautosomaldominantpolycystickidneydisease
AT riyahisadjad pericardialeffusiononmriinautosomaldominantpolycystickidneydisease
AT blumenfeldjon pericardialeffusiononmriinautosomaldominantpolycystickidneydisease
AT kimjiwon pericardialeffusiononmriinautosomaldominantpolycystickidneydisease
AT rennerthanna pericardialeffusiononmriinautosomaldominantpolycystickidneydisease
AT princemartinr pericardialeffusiononmriinautosomaldominantpolycystickidneydisease